Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 4:56 pm Purchase |
2025-03-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
RA Capital Management, L.P. | 1,328,578 9.900% |
176,566 (+15.33%) |
Filing History |
| 2025-05-15 4:39 pm Purchase |
2025-03-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 1,224,339 9.990% |
136,424 (+12.54%) |
Filing History |
| 2025-05-15 08:30 am Unchanged |
2025-03-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Vivo Opportunity Fund Holdings, L.P. | 6,096,173 9.990% |
0 (Unchanged) |
Filing History |
| 2025-02-14 6:43 pm Purchase |
2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
RA Capital Management, L.P. | 1,152,012 9.900% |
104,775 (+10.00%) |
Filing History |
| 2025-02-14 4:39 pm Purchase |
2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
GREAT POINT PARTNERS LLC | 1,147,317 9.990% |
195,073 (+20.49%) |
Filing History |
| 2025-02-06 3:08 pm Unchanged |
2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Walleye Capital LLC | 500,000 4.820% |
0 (Unchanged) |
Filing History |
| 2024-12-20 4:32 pm Purchase |
2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 1,087,914 9.990% |
71,979 (+7.09%) |
Filing History |
| 2024-12-20 4:31 pm Sale |
2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY |
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 300,902 2.760% |
-487,882 (-61.85%) |
Filing History |
| 2024-11-14 7:13 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
Logos Global Management LP | 507,893 4.900% |
507,893 (New Position) |
Filing History |
| 2024-11-14 7:01 pm Purchase |
2024-10-09 | 13G | Unicycive Therapeutics, Inc. UNCY |
Vivo Opportunity Fund Holdings, L.P. | 6,096,173 9.990% |
100,000 (+1.67%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
RA Capital Management, L.P. | 1,047,238 9.990% |
700,027 (+201.61%) |
Filing History |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
GREAT POINT PARTNERS LLC | 952,243 9.990% |
96,343 (+11.26%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 1,015,935 9.990% |
668,364 (+192.30%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 788,784 7.760% |
576,608 (+271.76%) |
Filing History |
| 2024-11-14 4:29 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
BIOTECHNOLOGY VALUE FUND L P | 1,047,123 9.990% |
700,101 (+201.74%) |
Filing History |
| 2024-11-13 4:52 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
Walleye Capital LLC | 500,000 5.300% |
500,000 (New Position) |
Filing History |
| 2024-10-11 4:02 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
Octagon Capital Advisors LP | 855,900 9.100% |
855,900 (New Position) |
Filing History |
| 2024-07-18 4:10 pm Purchase |
2024-07-16 | 13G | Unicycive Therapeutics, Inc. UNCY |
GREAT POINT PARTNERS LLC | 855,900 9.990% |
855,900 (New Position) |
Filing History |
| 2024-02-14 6:41 pm Purchase |
2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
RA Capital Management, L.P. | 347,211 9.990% |
142 (+0.04%) |
Filing History |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 347,571 9.900% |
226,830 (+187.86%) |
Filing History |